<DOC>
	<DOC>NCT02580929</DOC>
	<brief_summary>This study aims to evaluate the effectiveness of radiotherapy before surgery in high-risk relapse hepatocellular cancer patients.</brief_summary>
	<brief_title>Clinical Study of Effectiveness of Radiotherapy Before Surgery in High-risk Relapse Hepatocellular Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Hepatocellular</mesh_term>
	<criteria>1. Clinical diagnosis of HCC 2. In high risk of recurrence of HCC but still can endure palliative resection 3. KPS scores are &gt;90 4. With ChildPugh Class A liver funcion, serum bilirubin&lt; 1.5*normal maxism; ALT and AST&lt; 1.5*normal maxism; normal creatinine and urea nitrogen; WBC&gt;4×109/L, Hb&gt;110g/L, PLT&gt;90X109/L. 5. Have signed informed consent 1. HCC cannot be operated 2. With ChildPugh Class B/C 3. Have other organ cancer, excluding curative nonmelanotic skin cancer and carcinoma in situ of cervix 4. Have other severe disease 5. With active hepatitis 6. Have accepted local radiation therapy in other hospitals 7. KPS scores≤70 8. Tumor edges cannot be defined 9. Have severe cirrhosis complication 10. Intensity modulated radiation therapy cannot reach required dose 11. Cannot cooperate 12. Lactant or pregnant 13. Cannnot be informed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Radiotherapy</keyword>
	<keyword>General Surgery</keyword>
</DOC>